Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)
2009 ◽
Vol 75
(3)
◽
pp. S386-S387
2014 ◽
Vol 90
(1)
◽
pp. S535
2020 ◽
Vol 106
(3)
◽
pp. 564-570
◽
2013 ◽
Vol 87
(2)
◽
pp. S469
2011 ◽
Vol 81
(2)
◽
pp. S545